Thyroid medication described as 'subpotent drug' recalled by FDA
The FDA has issued a recall for specific batches of Levothyroxine Sodium tablets due to concerns regarding subpotent dosages. This medication serves as a common treatment for hypothyroidism, and patients relying on it for hormone regulation must verify their prescription information immediately. When a thyroid medication fails to meet potency standards, the physical impact on a patient can be significant, potentially leading to the return of symptoms or improper thyroid management.
Patients should check their medicine cabinet for the specific lot numbers identified in the official FDA announcement. If your medication matches the affected lot numbers, do not stop taking the drug abruptly. Consult with a pharmacist or physician to secure a replacement or verify the safety of your current supply. This step is critical to ensure continuity of care and stable hormone levels.
Pharmaceutical manufacturers are required to maintain strict chemical standards to ensure every pill contains the exact dosage listed on the label. Subpotency means the active ingredient strength falls below the regulated threshold, which creates a risk for those who require consistent dosing to manage their metabolic health. The recall process exists to remove these compromised batches from pharmacy shelves and prevent further distribution.
Contact your healthcare provider if you have experienced any changes in your health since starting a new refill. Pharmacy teams are equipped to identify whether your specific bottle is part of the recall and can provide guidance on how to return the product. Stay informed by checking the FDA website for the most recent updates on this recall action.